Plasma ddPCR for the detection of amplification in advanced NSCLC patients: a comparative real-world study

Background: Mesenchymal–epithelial transition ( MET ) amplification is a crucial oncogenic driver and a resistance mechanism to epidermal growth factor receptor tyrosine kinase inhibitors (TKIs) of non-small-cell lung cancer (NSCLC). Fluorescence in situ hybridization (FISH) is the gold standard for...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Jun-Wei Su, Cheng-Di Weng, Xiao-Cheng Lin, Mei-Mei Fang, Xiao Xiao, Yi-Chen Zhang, Xu-Chao Zhang, Jian Su, Chong-Rui Xu, Hong-Hong Yan, Hua-Jun Chen, Yi-Long Wu, Jin-Ji Yang
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	SAGE Publishing 2024-02-01
Edice:	Therapeutic Advances in Medical Oncology
On-line přístup:	https://doi.org/10.1177/17588359241229435
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!